ObsEva (XSWX:OBSN) Accounts Payable & Accrued Expense : CHF2.06 Mil (As of Dec. 2022)

View and export this data going back to 2018. Start your Free Trial

What is ObsEva Accounts Payable & Accrued Expense?

ObsEva's quarterly accounts payable & accrued expense declined from Jun. 2022 (CHF15.31 Mil) to Sep. 2022 (CHF8.03 Mil) and declined from Sep. 2022 (CHF8.03 Mil) to Dec. 2022 (CHF2.06 Mil).

ObsEva's annual accounts payable & accrued expense increased from Dec. 2020 (CHF16.59 Mil) to Dec. 2021 (CHF18.14 Mil) but then declined from Dec. 2021 (CHF18.14 Mil) to Dec. 2022 (CHF2.06 Mil).

ObsEva Accounts Payable & Accrued Expense Historical Data

The historical data trend for ObsEva's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ObsEva Accounts Payable & Accrued Expense Chart

ObsEva Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

14.45

16.67

16.59

18.14

2.06

ObsEva Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															18.14	18.73	15.31	8.03	2.06

ObsEva Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ObsEva (XSWX:OBSN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ObsEva SA (XSWX:OBSN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228

Website

https://www.obseva.com

ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of innovative women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.

ObsEva (XSWX:OBSN) Headlines

No Headlines